Study guide

7.2 Gallium, Thallium, Xenon, and Miscellaneous Agents

Certified Nuclear Medicine Technologist CNMT

Track your progress as you read

Finished sections get a check mark.

1 Introduction & Exam Overview

1.1 Current CNMT Exam Facts 1.2 How to Use This Guide

2 Radiation Physics Fundamentals

2.1 Radioactive Materials, Isotopes, and Decay Modes 2.2 Decay Calculations and Counting Statistics 2.3 Interactions of Radiation with Matter 2.4 Radiation Detector Types and Principles

3 Biological Effects & ALARA

3.1 Biological Effects of Radiation Exposure 3.2 ALARA and Protection Calculations 3.3 Dose Limits, Surveys, and Personal Monitoring

4 NRC & Regulatory Compliance

4.1 NRC Areas, Spills, Waste, and Records 4.2 Written Directives and DOT Shipping 4.3 EPA, OSHA, HIPAA, FDA, and USP Standards 4.4 Radioactive Waste Disposal and Regulatory Records

5 Generators & Kit Preparation

5.1 Radionuclide Generators and Quality Control 5.2 Radiopharmaceutical Kit Preparation 5.3 Radiopharmaceutical Quality Control

6 Tc-99m Diagnostic Agents

6.1 Tc-99m Cardiac Imaging Agents 6.2 Tc-99m Bone, Renal, and GU Agents 6.3 Tc-99m GI and Hepatobiliary Agents 6.4 Tc-99m CNS, Infection, and Labeled Cells

7 Non-Tc Diagnostic & PET Agents

7.1 Iodine and Indium Diagnostic Agents 7.2 Gallium, Thallium, Xenon, and Miscellaneous Agents 7.3 PET Radiopharmaceuticals 7.4 Neurologic, Breast, and Neuroendocrine PET Agents

8 Therapeutics, Adjuncts & Administration

8.1 Therapeutic Radiopharmaceuticals 8.2 Interventional and Adjunct Pharmaceuticals 8.3 Blood Labeling and Administration Techniques 8.4 Blockade, Comfort, and Gastrointestinal Adjunct Agents

9 Non-Imaging Instrumentation

9.1 Well Counters, Probes, and Survey Meters 9.2 Dose Calibrator Quality Control 9.3 Auxiliary and Patient Care Equipment

10 Imaging Systems & Quality Control

10.1 Gamma Camera Quality Control 10.2 SPECT and SPECT/CT Systems 10.3 PET and PET/CT Systems and QC 10.4 CT Systems, PACS, and Information Systems 10.5 CT Radiation Dose, Safety Alerts, and Protocol Optimization

11 Pulmonary, Bone, Oncology & Infection Imaging

11.1 Pulmonary Imaging Procedures 11.2 Bone and Musculoskeletal Imaging 11.3 Oncology Imaging Procedures 11.4 Infection Imaging Procedures

12 Renal, Endocrine & Hematopoietic Imaging

12.1 Renal and Genitourinary Imaging 12.2 Endocrine Imaging (Thyroid, Parathyroid, Adrenal) 12.3 Hematopoietic and Bone Marrow Imaging 12.4 Thyroid Uptake Measurement and Radioiodine Survey Technique

13 Cardiovascular Procedures

13.1 Myocardial Perfusion Imaging 13.2 Cardiac Function, Viability, and Special Studies 13.3 Exercise and Pharmacologic Stress Testing

14 GI, CNS, Therapy & Hybrid CT Procedures

14.1 Gastrointestinal Procedures 14.2 Central Nervous System Procedures 14.3 Radionuclide Therapy Procedures 14.4 CT and Hybrid Imaging in Nuclear Medicine 14.5 CSF Studies: Cisternography, Leak Localization, and Shunt Patency

15 Patient Care & Clinical Workflow

15.1 Patient Care, Education, and Consent 15.2 Scheduling and Radiopharmaceutical Procurement 15.3 Acquisition, Positioning, and Image Quality 15.4 Image Processing and Quantitative Analysis 15.5 Non-Imaging Studies: Specimens, Counting, and Error Analysis

7.2 Gallium, Thallium, Xenon, and Miscellaneous Agents

Key Takeaways Explain This Topic AI

Ga-67 citrate (t½ ≈ 78 h; gammas near 93, 185, 300, and 394 keV) behaves as an iron analog bound to transferrin; classic uses are infection/inflammation and selected tumors (use declining but still tested)

Tl-201 thallous chloride (t½ ≈ 73 h; Hg x-rays ~69–83 keV and 167 keV gamma) is a K+ analog via Na+/K+ ATPase with redistribution—historical MPI and viability teaching staple

Xe-133 gas (t½ ≈ 5.3 d; 81 keV) is an inert ventilation agent requiring negative-pressure room control, exhaust, and trap/charcoal systems

Vs Tc alternatives: MPI now usually Tc-99m sestamibi/tetrofosmin; infection often Tc- or In-labeled WBCs or FDG PET; ventilation often Tc-99m DTPA aerosol/Technegas where available

Traps: multi-peak Ga-67 window setup, Tl-201 soft-tissue attenuation and long biologic retention teaching points, and xenon room contamination or missing trap checks

Last updated: August 2026

7.2 Gallium, Thallium, Xenon, and Miscellaneous Agents

Quick Answer: Ga-67 citrate → iron/transferrin pathway for infection and selected tumors (multi-energy, ~78 h). Tl-201 → K+ analog (Na+/K+ ATPase) with redistribution for historical MPI/viability. Xe-133 → inert ventilation gas (81 keV) with negative-pressure room + trap . Know why Tc/PET alternatives often win clinically—and why exams still ask these nuclides.

  • Gallium-67 Citrate
  • Physics and Mechanism

Ga-67 decays by electron capture with a physical half-life of about 78 hours (~3.3 days) . Principal gammas used for imaging cluster near 93, 185, 300, and 394 keV —cameras need correct multi-energy window setup and often medium-energy collimation.

After IV injection as gallium citrate , gallium behaves as an iron analog : it binds transferrin in plasma and localizes at sites of infection/inflammation and some tumors via increased blood flow, capillary permeability, lactoferrin binding in neutrophils, and siderophore-related bacterial uptake pathways (exam-level simplification: iron-analog / transferrin-mediated localization ).

  • Item Typical teaching values
  • Half-life ≈ 78 h
  • Energies 93, 185, 300, 394 keV (multi-peak)
  • Adult activity Often ~5–10 mCi (185–370 MBq) IV
  • Imaging times ~ 24, 48, and sometimes 72 h (infection protocols vary)
  • Excretion notes Bowel and urinary activity—delayed imaging and bowel prep may help
  • Indications (Still Tested)
  • Fever of unknown origin / chronic infection workups (especially when labeled WBC imaging is limited)
  • Osteomyelitis (selected contexts; spinal infection historically)
  • Lymphoma and other tumors (historical staging/restaging—largely superseded by F-18 FDG PET/CT )
  • Sarcoidosis and other granulomatous disease patterns in older literature
  • Why Use Is Declining

FDG PET/CT and labeled leukocytes usually offer better logistics or specificity for modern pathways. CNMT items still expect Ga-67 physics, transferrin mechanism, delayed multi-day imaging, and bowel activity as an interpretation confounder.

Traps

Wrong energy windows (missing peaks) tank counts. Recent chemotherapy, gadolinium, or iron overload can alter biodistribution. Normal liver, spleen, bone marrow, and lacrimal/nasal activity can confuse newcomers. Do not expect Ga-67 to be a first-line PE ventilation agent or MPI tracer.

  • Thallium-201 Thallous Chloride
  • Physics and Mechanism

Tl-201 (t½ ≈ 73 hours ) decays by electron capture. Imaging relies mainly on mercury x-rays ~69–83 keV plus a 167 keV gamma. Soft-tissue attenuation is worse than for Tc-99m 140 keV photons.

Thallous ion (Tl⁺) is a potassium analog . Myocardial uptake uses the Na+/K+ ATPase pump and is proportional to blood flow and viable myocytes . Unlike Tc-99m sestamibi/tetrofosmin, Tl-201 shows clinically important redistribution : after a stress injection, serial imaging can show fill-in of ischemic but viable territories as tracer redistributes from other regions.

  • Feature Tl-201 teaching profile
  • Mechanism K+ analog; Na+/K+ ATPase
  • Classic uses Stress/redistribution MPI ; viability (rest-redistribution protocols)
  • Typical adult activity Often ~2–4 mCi (74–148 MBq) IV (lower than Tc MPI mCi amounts)
  • Imaging Stress images early after injection; redistribution ~ 3–4 h (sometimes 24 h for viability)

Compared with Tc agents Better redistribution physiology teaching; worse counts, attenuation, and dosimetry for many protocols

Viability vs Perfusion Teaching Point

A fixed defect on Tc MPI may still be evaluated for viability with metabolic FDG PET or thallium rest-redistribution strategies—exam stems love “ redistribution implies viable myocardium ” language for thallium. Do not claim Tc-sestamibi has the same robust redistribution behavior.

Traps

Breast and diaphragm attenuation; low-energy scatter; confusing thallium with technetium dose magnitudes; injecting at wrong stress timing; and treating thallium as a ventilation or bone agent.

  • Xenon-133 Gas
  • Physics and Mechanism

Xe-133 is a noble-gas ventilation agent. Physical half-life ≈ 5.3 days ; primary photon ≈ 81 keV . Patients inhale Xe-133 mixed in air/oxygen via a closed delivery system. Because xenon is lipophilic and inert , it distributes in aerated lung and washes out with ventilation; there is also potential fat solubility and soft-tissue background with delayed clearance in obese patients.

  • Phase (classic Xe study) What you see
  • Single-breath / washin Initial ventilation map
  • Equilibrium Rebreathing fills ventilated regions
  • Washout Clearance; air trapping retains activity (e.g., obstructive disease)

Adult administered activities are often in the 5–20 mCi inhaled range depending on system and protocol (know order of magnitude and that it is inhaled gas , not IV MAA).

Room Preparation and Engineering Controls

Xe-133 is a radioactive gas —contamination control is a regulatory and safety favorite:

  • Control Why it matters
  • Negative-pressure imaging room (relative to corridor) Contains leaked gas
  • Dedicated exhaust / monitoring Prevents department spread
  • Charcoal trap or approved trapping system on the delivery unit Captures exhaled Xe-133
  • Trap saturation checks / replacement schedule Saturated traps release activity
  • Door discipline and spill/leak drills Limit worker/public exposure
  • Pregnancy policies / posting Gas studies have unique airborne pathways

After a leak, survey and evacuate/ventilate per radiation-safety procedures—do not treat it like a liquid Tc spill only.

Xe-133 vs Tc Ventilation Alternatives

  • Agent Form Strength Limitation
  • Xe-133 Gas True gas washout physiology; widely tested Room controls; 81 keV; soft-tissue background

Tc-99m DTPA aerosol Nebulized liquid droplets Uses Tc energy/collimators; easier room control Central airway deposition if poor technique; not a true gas

Technegas (where available) Ultrafine carbon particles Excellent peripheral penetration Availability/regulatory status varies

PE workups pair ventilation with Tc-99m MAA perfusion . Know which mismatch patterns matter clinically, but this section’s job is agent + room physics .

Quick “When Would You Still See These?”

  • Clinical need Legacy agent Common modern alternative
  • Infection / FUO / selected tumor Ga-67 citrate Labeled WBCs; F-18 FDG PET/CT
  • MPI with redistribution teaching / viability history Tl-201 Tc-99m sestamibi/tetrofosmin; FDG viability PET
  • Ventilation for V/Q Xe-133 Tc-99m DTPA aerosol or Technegas

Bottom line for CNMT: even when your clinic rarely orders Ga-67 or Tl-201, the exam still expects half-life, energy, mechanism, and the xenon room checklist .